Septerna, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SEPN Nasdaq 2834 septerna.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Septerna, Inc.

Septerna (SEPN) Heads To Healthcare Conferences, Is The Valuation Already Too Rich? - Sep 14th, 2026 8:10 am
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sep 10th, 2026 2:00 pm
Septerna to Participate in Upcoming Investor Conferences - Sep 1st, 2026 6:00 am
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - Aug 25th, 2026 6:00 am
Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates - Aug 10th, 2026 3:10 pm
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results - Aug 10th, 2026 2:01 pm
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates - Aug 5th, 2026 7:00 am
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? - Jul 5th, 2026 7:55 am
Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment? - Jul 2nd, 2026 1:58 pm
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares? - Jun 29th, 2026 9:25 pm
Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting - Jun 8th, 2026 6:00 am
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer - Jun 8th, 2026 5:00 am
Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts - May 17th, 2026 8:47 am
Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their Estimates - May 15th, 2026 8:08 am
Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates - May 11th, 2026 3:25 pm
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results - May 11th, 2026 2:01 pm
How Analyst Upgrade and Conference Spotlight Will Impact Septerna (SEPN) Investors - May 8th, 2026 7:19 am
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 5:05 pm